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Fetal alcohol syndrome (FAS) is a complex and malformative condition due to the teratogenic effect of alcohol consumed 
during pregnancy. Several epidemiological studies have shown that maternal alcohol use during pregnancy is the most common 
preventable cause of mental retardation in childhood. The effects of alcohol on the fetus range from abortion to a spectrum of 
clinical manifestations called Fetal Alcohol Spectrum Disorders (FASD) that includes partial FAS (PFAS), neonatal Alcohol 
Related Birth Defects (ARBD) and Alcohol Related Neurodevelopmental Disorders (ARND) up to the most severe disease which 
is the so-called FAS. Biomed Rev 2018; 29: 27-35
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Key messages (Highlights)
1) FASD represents the most common acquired mental retardation, which is totally preventable. 
2) The threshold dose of teratogenic alcohol damage is not known, therefore absolute abstention during pregnancy is indicated. 
during pregnancy, therefore all genetic conditions with similar clinical characteristics must be sought.
R e v i e w
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INTRODUCTION
Fetus alcohol syndrome (FAS) is a complex malformative 
condition of the newborn and the child, described by Lemoine 
effect of alcohol taken during pregnancy (4–16). It is the 
most common cause of mental retardation acquired in 
childhood, therefore totally avoidable, through the complete 
abstention of the pregnant woman from the consumption 
of alcohol. The effects of alcohol on the fetus range from 
the absence of damage to abortion, including a spectrum of 
clinical manifestations called FASD (Fetal Alcohol Spectrum 
Disorders) which, in addition to FAS, includes partial FAS 
(PFAS), associated neonatal congenital defects (Alcohol 
Related Birth Defects, ARBD) and neurological development 
disorders (Alcohol Related Neurodevelopmental Disorders, 
ARND) (17). Although FASD is a common cause of disability, 
Italy or in the world, but only sporadic reports. This probably 
leads to an underestimation of the problem and does not 
facilitate the correct diagnosis and the possible rehabilitation 
of numerous children with mental retardation. However, the 
global prevalence of FASD is about 0.77%, the European 
prevalence is 0.19%, while in the US it is about 2-5%. The 
only Italian data concerns the prevalence in Lazio, which for 
the FAS is 3.7-7.4:1000 and for the FASD is 2-4% (18–22).
WHY CAN THE PEDIATRICIAN SUSPECT IT?
In the neonatal age, FAS can be suspected in the presence of 
a small gestational age with microcephaly and typical dys-
morphisms (23–25). The microcephaly data is salient because 
the preterm newborns are generally relatively macrocephalic. 
During childhood, the diagnosis is easier because, in addition 
to the growth defect and facial dysmorphic signs, psychomotor 
retardation, behavioral disorders and attention and concentra-
signs of the pediatric age can be added behavioral, scholastic 
and, above all, social problems.
understand the behavior of the mothers, which demonstrate 
responsibility, control, balance, care and attention to the 
newborn. Indeed, it has been shown that mothers who have 
substantial defects in these spheres, are those who drink even 
during breastfeeding, exposing the infant to an increased risk 
of impaired abilities at 6 years (26), even if they did not drink 
during pregnancy. In fact, the alcohol for 30-60 min after inges-
tion, maintains in the milk the same levels of maternal blood, 
in quantities equal to 5-6% of the ingested dose and with a 
half capacity to be metabolized by the newborn.
CLINICAL CRITERIA FOR DIAGNOSIS
Due to the lack of diagnostic genetic or biochemical tests, the 
decisive step in identifying a child with FASD is to ascertain 
maternal alcohol consumption during pregnancy (27–32). 
to the guilty feelings of mothers, however, does not exclude 
the diagnosis, which must be formalized following the recent 
guidelines (33, 34) that are based on the multidisciplinary 
approach to the mother-child dyad and aimed at analyzing 3 
essential aspects of the syndrome (26, 35–37):
1) Morphological abnormalities of the newborn,
2)  Neuropsychological, intellectual and social development 
of the child,
3) Maternal risk factors.
The diagnostic guidelines subdivide the FASD in various 
forms.
I - FAS (all A-D criteria required)
With or without  of maternal intake of alcohol 
during pregnancy
A. Presence of two or more facial abnormalities between: 
1. Short palpebral  (< 10th percentile)
2. Thin upper lip (score 4 or 5)
3. Long and  philtrum (score 4 or 5)
B.  Pre-postnatal growth rate (height and / or weight < 10th 
percentile per age)
C.  Microcephaly or cerebral structural anomalies or 
recurrent non-febrile convulsions
D. Neurobehavioral  (< or > of 3 years)
< 3 years: mental retardation: > 1.5 SD below average
> 3 years
1) With cognitive defect
a)  Global: general conceptual ability or verbal, 
spatial, performance IQ:  
> 1.5 SD below average
b)  At least 1 neuro-behavioral domain among, 
executive functions, language, memory, visual-
spatial ability: > 1.5 SD below average
2) With behavioral disorders, without cognitive defect.
 in at least 1 domain between mood 
regulation, attention, control of the pulses:  
> 1.5 SD below the average
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II - partial FAS
A-B criteria required
A.  Presence of two or more of the facial anomalies (point A 
of the complete FAS)
C. Pre- and/or postnatal growth retardation
III - ARND required criteria A and B (diagnosis cannot be 
placed in children <3 years)
pregnancy
B.  Cognitive-behavioral abnormalities (point D of the 
complete FAS)
IV - ARBD required criteria A and B
pregnancy
B.   Congenital structural defects (one or more of the heart, 
kidneys, skeletal, ears, eyes and minor anomalies)
CLINICAL PICTURE AND MEDICAL COMPLICATIONS
Growth retardation: individuals with FASD, almost con-
stantly, show postnatal growth retardation that occurs dur-
ing the prenatal period because exposure to fetal alcohol, 
especially in the third trimester, strongly reduces somatic 
development. Infants may be small for gestational age and 
remain below the stature average even during the develop-
ment. Some children with FASD, probably because they 
were not exposed to alcohol in the last trimester, may have 
normal growth parameters but, secondarily, develop learn-
Facial anomalies
and thin upper lip. They may also have minor associated 
root with a short nose with antiverse nostrils, hypoplasia of 
the cheekbones, anomalies of positioning of the ears with 
a “railway track” appearance of the antihelix cartilage and 
micrognathia. (Fig. 1)
FASD, can be performed using some standard reference guides, 
Figure 1. Standard guide for the lip and the philtrum (SCORE 
1-2 Normal; 3-5 Possible FAS). 
such as the lips and philtrum, (Fig. 2) that transform some 
clinical aspects into numerical data (score 1-5) and with the 
aid of the percentiles of growth percentages, by age and sex, of 
a rigid ruler, possibly transparent.
Structural Congenital Defects
These include anomalies of various organs such as:
• Heart: (25-50%): inter-atrial or inter-ventricular defects, 
cono-truncal anomalies or large vessels.
• Kidneys (4%): aplasia, hypoplasia, renal dysplasias, 
horseshoe kidneys, rheno-ureteral duplications.
• Skeleton: with radio-ulnar synostosis, vertebral segmentation 
defects with cervical vertebrae fusion (50%), ankylosis of 
large joints, scoliosis (15%).
• Ears: mixed (90%) or sensorineural (30%) hearing loss.
• Eyes: microphthalmia, strabismus, palpebral ptosis and 
retinal vascular anomalies with associated visual defect.
• Teeth: frequent caries, ogival palate and Class III 
malocclusion with growth.
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• Minor dysmorphic anomalies such as: hypoplastic nails, 
handheld “hockey stick” and pectus excavatum/carinatum.
Abnormalities of the Central Nervous System
Numerous studies on the damage due to itrauterine exposure to 
alcohol show a range of short-term and long-term cognitive and 
behavioral outcomes deriving from structural and functional 
central nervous system abnormalities.
The main structural alteration of FASD is microcephaly, 
often accompanied by low overall growth. Magnetic 
resonance imaging (MRI) studies show an overall reduction 
in brain volume and a disorganization of the central nervous 
alcohol vulnerable areas such as corpus callosum (agenesis, 
hypoplasia), cerebral cortex, cerebellum, caudate nucleus and 
alterations (51–54).
Functional disorders include neurological signs such 
seizures, whose incidence is not yet clear but which involve 
therapy (55–59).
CONFIRMATION EXAMS
measurements of stature, weight and cranial circumference 
are made, as well as the assessment of the length of the eyelid 
slits and of the philtrum. All these data are pathological if they 
and of the upper lip, which are qualitative data, have been 
made measurable as quantitative data by the use of the Lip-
Philtrum Guide. Once a syndromic picture is suspected, it is 
during pregnancy (maternal risk factors, adoption from Eastern 
European countries) and to search for congenital anomalies 
associated with brain, heart and abdominal ultrasounds, X-rays 
of the skeleton and brain MRI, EEG, audiometric test and eye 
examination, as well as to perform the genetic screening tests 
such as the examination of the karyotype and the CGH-array 
(60, 61). In this way, it is possible to make the differential 
diagnosis with the syndromes that have signs in common, such 
as chromosomal diseases and micro-deletions/duplications or 
other genetic syndromes (Table 1).
Figure 2. Typical facial signs of FAS children with essential 
lip. The dysmorphologic parameters must be detected at all 
ages, but if the patient’s facial signs have eased over time, the 
diagnosis of facial anomalies should be based on the period 
in which they were most expressed, possibly with the help of 
photos. In fact, it is important to observe how the facies of FAS 
sufferers remain basically unchanged over time.
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Table 1. Differential FASD diagnosis versus other syndromes
Syndromes Common signs with FASD     Differential features
Aarskog Syndrome
Small saddle nose, anteverse nostrils, 
ample philtrum, hypertelorism
Round face, palpebral ptosis, fold under 
the lower lip, dental rash problems
Williams Syndrome
Short palpebral fissures, anteverse nostrils, 
elongated philtrum, epicanthus, saddle 
nose
Wide mouth, star pattern of iris, 
periorbital swelling, cartilage disorders
Noonan Syndrome
Lowered nasal bridge, hypertelorism, 
epicanthus
Keratoconus, palpebral ptosis, broad 
mouth with protrusion of the upper lip
Dubowitz Syndrome
Short palpebral fissures, hypertelorism, 
epicanthus
Low supraorbital ridge with nose bridge 
at the level of the forehead
Brachmann-De Lange Syndrome
Elongated philtrum, thinned upper lip, 
depressed nasal bridge
Single bush eyebrow along the forehead, 
long eyelashes, short limbs, acute arch 
palate
Toluene embryopathy
Short palpebral fissures, median face 
hypoplasia, thinned upper lip
Micrognathia, open front fontanelle, hair 
anomalies, bifrontal narrowing
Fetal Hydantoin Syndrome, also 
called Fetal Dilantin Syndrome
Hypertelorism, depressed nasal bridge Short nose with upper arched lip
Fetal Valproate Syndrome
Anteverse niches, elongated philtrum, 
hypertelorism
High forehead, infraorbital fold, small 
mouth
Effects on the fetus of maternal 
phenylketonuria
Epicanthus, short palpebral rhymes, 
flattened philtrum, thin upper lip
Small saddle nose, prominent glabella, 
rounded face
In fact, a diagnosis of FASD in a child with disability cannot 
be automatically set-up simply because the mother has taken 
is missing, the diagnosis of FASD must be considered as a 
diagnosis of exclusion (27, 28, 62).
INTELLECTUAL PROGNOSIS AND SURVIVAL
In patients with FASD, when mental retardation is present, 
it persists, but with improvements related to rehabilitation 
therapies. Psycho-behavioral problems, if not recognized and 
early treated, can promote the deterioration of quality of life. 
Long-lasting mental retardation could overlap with alcohol 
use disorders during the adult life (63–66).
It was found (67–69) that among people aged 6 to 51 years 
affected by FASD:
•  94% have mental health problems and in 23% of these 
people mental illness requires hospital assistance
•  83% of adults have problems with addiction
•  79% of adults have employment problems
Instead, in boys over the age of 12 it has been reported that:
•  61% have a disruptive school experience
•  60% have problems with the law
•  49% assume inappropriate sexual behavior
•  35% have alcohol/drug problems
KNOWN MEDICAL COMPLICATIONS 
Although recently the use of alcohol in pregnancy has been 
correlated with an increased risk of sudden infant death 
syndrome (70), the main complications attributable to 
FASD frameworks are mainly related to neurocognitive and 
of understanding, and the disturbances of the attention (71). 
However, mental retardation is not a constant feature of the 
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syndrome because the child’s IQ can vary from a normal range 
reasoning, planning, judgment, problem solving, monitoring) 
behavior, emotional lability, poor academic performance and 
lack of social interaction) are very frequent and enormously 
impair social adaptation (72).
CONCLUSION
The issue of lifelong disabilities caused by alcohol drinking 
during pregnancy is quite problematic at familial, individual 
and societal level. As far as a nontoxic consumption behavior 
during gestation cannot be established, for the extremely 
individual conditions of vulnerability to alcohol (73), the 
only suggestion for women planning pregnancies, or during 
gestation and lactation is to totally avoid the consumption of 
alcoholic beverages.
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